Sep 12, 2024 7:00am EDT ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
Sep 5, 2024 7:00am EDT ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference